PI-LAB-2026-180
Semaglutide (Oral), Independent Lab Report
Semaglutide (Oral) 14mg · Meridian Health Direct
Independent testing verdict Pass
This product matched its label.
Identity confirmed and measured purity of 97.5% met the stated ≥98% claim. Content measured 99.3% of label.
- Identity verified
- Yes
- Measured purity
- 97.5%
- Content accuracy
- 99.3%
- Test recency
- Current cycle
Mass spectrometry confirmed the labelled compound
Label claimed ≥98%
13.9mg measured against 14mg claimed
Published 8 months ago
Specimen PI-LAB-2026-180 Tested by Vantage Analytical Labs 8 samples tested from this company Purity & Testing score 97/100
Full laboratory evidence Findings table, methodology, chain of custody and the original report
Findings
| Metric | Label claim | Measured | Assessment |
|---|---|---|---|
| Purity (HPLC) | ≥ 98% | 97.5% | Within analytical tolerance |
| Identity (MS) | Semaglutide (Oral) | Confirmed | Matches label |
| Content | 14 mg | 13.9 mg | Within 5% of label |
Methodology & chain of custody
Reversed-phase HPLC purity analysis with UV detection at 214nm.
The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.
- Lot / batch
- R6360-26
- Purchased
- Analysed
- Published
- Laboratory
- Vantage Analytical Labs
- Test type
- Purity & identity
Original laboratory report: PI-LAB-2026-180-report.pdf